Biohaven Pharmceuticals (BHVN)

[crudeoil24]

Press Release: Biohaven And Royalty Pharma Announce Royalty Funding And Stock Purchase Agreements Totaling $150 Million
8:06 pm ET June 18, 2018 (Dow Jones) Print
Biohaven And Royalty Pharma Announce Royalty Funding And Stock Purchase Agreements Totaling $150 Million

- Royalty Pharma acquires approximately 2% royalty rights on global annual net sales of rimegepant and BHV-3500 from Biohaven for $100 million

- Royalty participation rate subject to reduction to 1.50% on global annual net sales exceeding $1.5 billion

- Royalty Pharma agrees to acquire 1,111,111 Biohaven common shares for $50 million, at a price of $45.00 per share, representing an approximately 19% premium over the 15-day volume-weighted average price

PR Newswire

[ronpopeil]

i don't know but it looks like they are rebuilding the company. they have positions in several early stage companies so who knows. i feel at these levels the company is undervalued

[bbhuey]

I wonder when ptgef will be selling their shares of bhvn they still have. I u understand they are seeding another. Bio for $2M committment.I would assume they are waiting for phase 3 results.

[ronpopeil]

PTGEF is undervalued big time. BHVN surged again. PTGEF should be much higher based on their 6+ million share ownership of BHVN. That doesn't even factor in their ownership in other promising companies

[nohypeneeded]

BHVN new highs...makes PTGEF a steal under .45

[nohypeneeded]

Priced tonight...should be at high end....and opens NYSE tomorrow.
Keep in mind Portage Biotech (OTC: PTGEF) is largest holder and another way to play BHVN